TITLE:
Intranasal Civamide for Episodic Cluster Headache

CONDITION:
Episodic Cluster Headache

INTERVENTION:
Civamide (Zucapsaicin)

SUMMARY:

      This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in
      the treatment of an episodic cluster headache period compared to placebo (medically inactive
      substance which does not contain any active ingredients).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        -  At least 2 year history of episodic cluster headache (meeting IHS criteria)

          -  At least 2 previous episodes

          -  Expected duration of cluster period is at least 6 weeks but not longer than 24 weeks

          -  At least 1 but not more than 8 headaches on each of the 3 days immediately prior to
             treatment
      
